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STUDY PROTOCOL Open Access
Dialectical behaviour therapy for treating
adults and adolescents with emotional and
behavioural dysregulation: study protocol
of a coordinated implementation in a
publicly funded health service
Daniel Flynn1, Mary Kells3, Mary Joyce2*, Catalina Suarez2 and Conall Gillespie2
Abstract
Background: In the Republic of Ireland, borderline personality disorder (BPD) is a feature of approximately 11–20%
of clinical presentations to outpatient clinics within mental health services. These estimates are similar to other countries
including the UK and USA. Dialectical behaviour therapy (DBT) is an intervention with a growing body of evidence that
demonstrates its efficacy in treating individuals diagnosed with BPD. While a number of randomised controlled trials
(RCTs) have demonstrated the efficacy of DBT, there is limited research which evaluates the effectiveness of this model
when applied to real world settings. Funding was secured to co-ordinate DBT training in public community-based mental
health services across Ireland. As no other study has evaluated a co-ordinated national implementation of DBT, the
current study proposes to investigate the effectiveness of DBT in both adult and child/adolescent community mental
health services across Ireland, evaluate the coordinated implementation of DBT at a national level, and complete a
comprehensive economic evaluation comparing DBT versus treatment-as-usual.
Methods/ design: This study takes the form of a quasi-experimental design. Individuals attending community mental
health services who meet criteria for participation in the DBT programme will be allocated to the intervention group.
Individuals who live in areas in Ireland where DBT is not yet available, and individuals who choose not to participate in
the intervention, will be invited to participate in a treatment-as-usual comparison group. Self-report clinical measures and
health service use questionnaires for DBT participants (and parent/guardians as appropriate) will be administered at pre-,
mid- and post-intervention, as well as follow-up for participants who complete the intervention. Survey and interview
data for DBT therapists will be gathered at three time points: prior to DBT training, 6 months after teams begin delivery
of the intervention, and 2 years following training completion.
Discussion: It is anticipated that the results of this study will provide evidence for the effectiveness of DBT for patients,
and report on recommendations regarding best practice guidelines for implementation of DBT and its economic merit in
a publicly funded service.
Trial registration: ClinicalTrials.gov ID: NCT03180541; Registered June 7th 2017 ‘retrospectively registered’.
Keywords: Dialectical behaviour therapy, Borderline personality disorder, Effectiveness, Implementation, Economic cost,
Adults, Adolescents, Public health service, Community settings
* Correspondence: maryc.joyce@hse.ie; marychjoyce@gmail.com
2National Suicide Research Foundation, Western Gateway Building, University
College Cork, Cork, Ireland
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Flynn et al. BMC Psychiatry  (2018) 18:51 
https://doi.org/10.1186/s12888-018-1627-9
Background
Borderline personality disorder (BPD) is a mental health
diagnosis characterised by a pervasive pattern of instabi-
lity of interpersonal relationships, self-image, affect, and
marked impulsivity [1]. BPD typically features patterns
of cognitive, emotional and behavioural dysregulation
that often manifests in self-harm and suicidal behaviours
[2]. BPD is recognised as one of the most distressing dis-
orders for individuals and their families, and the most
difficult for clinicians to treat. The prevalence of BPD in
the general population is reported to be between 0.7%
and 1% [3–5]. 10% of outpatients and up to 20% of
psychiatric inpatients have this disorder [1]. In the Re-
public of Ireland, it is estimated that BPD is a feature of
11–20% of clinical presentations to outpatient clinics
within mental health services [6]. This is similar to what
has been recorded in other countries including the
United Kingdom [7], North America [8] and other parts
of Europe (e.g. Denmark [9]).
Given the prevalence rates of BPD, there is a growing
interest in providing evidence-based treatment for indi-
viduals with emotional and behavioural dysregulation.
Multiple treatments such as dialectical behaviour ther-
apy [10–12], schema therapy [13], mentalisation based
therapy [14], and transference focused psychotherapy
[15] have been developed for treating BPD. Dialectical
behaviour therapy (DBT) is the most researched
treatment option with more than a dozen randomised
controlled trials (e.g. [16–18]) which have investigated
its efficacy at multiple independent sites [19, 20].
Participation in DBT is associated with reductions in a
range of difficulties reported by individuals with BPD in-
cluding: suicidal behaviour [17, 21–23], suicidal ideation
[24, 25], BPD symptoms [26], hopelessness [24] and
depression [25, 26]. It has also been associated with
improved adjustment [22] and quality of life [23, 26], as
well as reduced health service utilisation and/or
inpatient psychiatric days [21, 23, 25, 26]. A recent sys-
tematic review of randomised studies has shown that
DBT is significantly better than treatment-as-usual in
terms of leading to reductions in self-harm, decreases in
ineffective expression of anger and improvement in
general functioning [27]. Although the number of rando-
mised controlled trials for the other listed treatments is
still limited, there is an emerging body of evidence
highlighting their benefits.
While DBT was initially developed for adults with a
diagnosis of BPD, in more recent years, this model has
been adapted to make it more developmentally appropri-
ate for adolescents presenting with borderline personal-
ity traits such as emotional dysregulation and self-harm
[28]. DBT for adolescents (DBT-A) utilizes a similar
format to standard DBT where it includes individual
therapy sessions, group skills training sessions, phone
coaching and weekly consultation meetings for the DBT
therapists. However, DBT-A also considers systemic
intervention where parent/guardians attend group skills
training with the adolescent. The DBT-A programme is
also shorter in length and is typically delivered as a
16 week programme. While the research evidence for
DBT-A is still in its infancy, reported outcomes are en-
couraging. To date, one randomised controlled trial
found DBT-A to be superior to enhanced usual care in
reducing self-harm, suicidal ideation and depressive
symptoms [29].
While the outlined research studies have demonstrated
the efficacy of DBT in treating BPD in controlled set-
tings, there is a dearth of published research reporting
on the effectiveness of DBT in publicly funded commu-
nity mental health settings. The few studies that have
been conducted in community settings have focused on
a 6 month DBT programme for adults (e.g. [30, 31]) or
have reported on cluster B personality presentations, in-
cluding but not focusing exclusively on BPD [32]. A
number of studies have also highlighted limitations with
regard to small sample sizes (e.g. [33, 34]). Comtois,
Elwood, Holdraft, Smith and Simpson [35] report on the
effectiveness of DBT in a community mental health
centre; however, the weekly skills groups were delivered
in two 90-min sessions, and the study trial also offered
individual DBT case management, both of which are dif-
ferent to the standard DBT programme.
In the Republic of Ireland, an Expert Group on Mental
Health published a government policy framework for
publicly funded community mental health services which
recommended DBT as an evidence-based treatment for
people with BPD [6]. As well as being endorsed by the
Irish expert group on mental health, DBT has been rec-
ommended by the American Psychiatric Association [36]
and more recently by the NHS National Institute for
Health and Clinical Excellence (NICE [37]) as being a
part of any comprehensive treatment programme for
patients with BPD and co-morbid presentations.
In line with best practice guidelines, and national men-
tal health policy frameworks, a number of community
services in Ireland endeavoured to establish DBT pro-
grammes in their locality. Prior to 2013, any such teams
were driven by clinician interest and in many instances,
failed to sustain as a result of systemic issues. Such is-
sues included lack of management support and funding
for training given that DBT had not been listed as a
mandated treatment in Irish national health service
plans. International research (e.g. [38, 39]) also highlight
a number of factors that can impact on effective imple-
mentation of DBT. Examples of such barriers include
lack of support from public mental health authorities
and programme leaders, and absence of organisational
support (including staff turnover, and funding for
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administration, training and supervision). Given positive
research outcomes on effectiveness of DBT in a separate
study across four sites in the south of Ireland [40], a Na-
tional Office for Suicide Prevention (established specific-
ally to drive suicide and self-harm prevention strategies
in the public health service in Ireland) agreed to fund
and support a project team to coordinate a multi-site
implementation of DBT in community settings at a na-
tional level [41]. As a result, the National DBT Project,
Ireland was established in 2013.
As no previous research has been conducted on a coor-
dinated national implementation of DBT in a publically
funded mental health system, it was deemed appropriate
and necessary to comprehensively evaluate this implemen-
tation effort. The research study has three primary aims;
first, to assess if individuals who participate in the DBT
intervention will achieve positive outcomes when the
intervention is delivered as part of a coordinated, multi-
site implementation; second, to investigate if a coordi-
nated implementation which addresses known implemen-
tation barriers will enable sustainable service provision;
and third, to investigate whether it is cost effective to im-
plement DBT versus treatment-as-usual in a publicly
funded community mental health setting.
Methods/ design
Study setting
Ireland’s public health service, the Health Service Execu-
tive (HSE) has the responsibility of delivering all public
health services in Ireland [42]. Approximately 10% of
individuals who experience mental health difficulties
require intensive, co-ordinated care which is accessed
through public mental health services. This secondary
level care encompasses more specialist interventions de-
livered by mental health practitioners such as psychia-
trists, psychologists, mental health nurses and other
professionals. The majority of mental health services in
Ireland are provided in the community, typically in out-
patient settings, day hospitals, day centres and at home
[6].
In Ireland, DBT is typically delivered in community
based mental health settings in the public health service
[41]. Within this context, core multi-disciplinary staff
from multiple community mental health teams are
seconded from their existing role to train in DBT and
offer this intervention as an evidence-based treatment
for individuals with BPD attending their local mental
health service. Thus, the setting for this study is Com-
munity Mental Health Services where participants at-
tend an outpatient community clinic to obtain the
intervention (see Flynn, Kells & Joyce [41] for further in-
formation on health service structure in Ireland). There
are 16 independent sites for this study which cover both
urban and rural areas in adult and child/adolescent men-
tal health services.
Study design
This study takes the form of a multi-site quasi-
experimental design with non-equivalent groups. As the
setting for this study is the publicly funded health sys-
tem, staff have a responsibility to treat every individual
who presents to the service. As a result, patients atten-
ding Community Mental Health Services who meet eli-
gibility criteria for participation in DBT will be offered
the intervention. At the onset of this study, there was no
alternative system wide evidence-based intervention
available for this client group that could have been used
for comparison purposes. Additionally, in abiding with
ethical guidelines and appropriate care of patients, nei-
ther is it possible to withhold treatment for individuals
who meet criteria for participation in the intervention.
Therefore, it was not possible to randomly allocate
participants to a DBT intervention, comparable inter-
vention or control group for the purposes of this
study. Given this limitation, a treatment-as-usual
comparison group was utilised which comprises of in-
dividuals who cannot access DBT in their area or
who opt out of DBT as a treatment option (but con-
tinue to engage in routine care).
Participants
Patients
Inclusion criteria The inclusion criteria for adults for
participation in the study are:
 Diagnosis (or meet criteria for diagnosis)
of borderline personality disorder (DSM-IV-TR,
[1]) or emotionally unstable personality disorder
(ICD-10, [43])
 A persistent pattern of self-harm behaviour or suicidal
behaviour, with the most recent episode having oc-
curred within the six months prior to being referred
to the intervention
 Will participate in all modes of treatment and have
committed to participate in the standard 12-month
DBT intervention
The inclusion criteria for adolescents are:
 Demonstrate emotional behavioural disturbance/
emotional dysregulation
 A persistent pattern of self-harm with self-harm be-
haviour or a suicidal act having occurred within the
last 16 weeks or chronic suicidal ideation reported
 The young person and their parent/guardian will
participate in the recommended modes of treatment
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and have committed to participate in the 16-week
DBT-A intervention
Patients who have co-morbid axis I and axis II disor-
ders are permitted to participate in this study as are
those who are also using medication.
Exclusion criteria The following exclusion criteria for
adults and adolescents apply:
 An active psychosis
 Severe developmental delays, cognitive impairment
or learning difficulties (that exceed the mild range)
 Substance/ drug dependence, eating disorder or any
other mental health issues/behaviour at such a level
that it would impede their engaging with any of the
modalities of DBT.
Treatment-as-usual
Study sites for the treatment-as-usual comparison group
will be based in areas where Community Mental Health
Teams have expressed an interest in DBT, but are unable
to complete training as a result of implementation bar-
riers during the four-year study period. Therefore, pa-
tients who reside in areas where the treatment is not yet
available, and who are engaged with their local Commu-
nity Mental Health Service, will be invited to participate
in the treatment-as-usual group. Additional treatment-
as-usual participants will be patients at intervention sites
who have been offered the treatment but have decided
not to partake at that time. The same inclusion/exclu-
sion criteria apply for treatment-as-usual participants as
for the intervention group except that participants are
not in a position to participate in all modes of DBT
treatment and/or commit to the full programme.
Parent/guardian of adolescent
For DBT programmes which are delivered in child/adoles-
cent mental health services, the adolescent’s parent/guard-
ian accompanies their child for the weekly group skills
training session. It should be noted that the parent/guard-
ian does not receive any therapeutic treatment as part of
the DBT programme. Miller, Rathus & Linehan [28] rec-
ommend the requirement of the same family member at-
tending each week and to make the same attendance
commitment as the adolescent. Potential situations where
family members may be excluded from the intervention
include the following:
 A parent’s work schedule or other obligations make
it impossible for him or her to attend
 Estrangement between the parent and the
adolescent
 There is such an intense degree of parent-adolescent
conflict that their being in a group together would
be likely to result in explosive or otherwise therapy-
destroying behaviour
 There is an ongoing abusive situation and the
adolescent is looking to maintain distance and safety
 A parent has a serious unmanaged mental disorder
Adolescents whose parent/guardian do not attend the
weekly group skills training will be retained in the study
as long as consent from a parent/guardian has been pro-
vided for the adolescent to participate in the research
study.
DBT therapists
All therapists who receive DBT training as part of the
National DBT Project, Ireland will be invited to partici-
pate in the study. The structure of DBT teams in Ireland
has followed the recommendations of the UK licensed
training provider of Intensive Training™ which specify
that teams who want to train in DBT must have a mini-
mum of four team members and a maximum of ten.1
Each team must have either a clinical/forensic/counsel-
ling psychologist OR a person with demonstrable gradu-
ate training in behaviour therapy. All teams must be
genuine teams i.e. who either are already or have explicit
plans to meet together to deliver a comprehensive DBT
programme to a group of clients in a single setting e.g.
out-patient adult clients. Each individual team member:
must be employed by a healthcare organisation that ex-
pects them to be seeing clients; must be registered to
practice with a regulatory professional body; must com-
mit at least 15 h per week to learning and delivering
DBT [44]. At each study centre, members of the DBT
team who receive DBT training as part of this project
will provide individual therapy to the patient, deliver the
weekly group skills sessions, provide phone coaching for
clients, and attend weekly team consultation meetings.
Intervention
Standard DBT for adults is delivered by a team of multi-
disciplinary mental health professionals, and comprises
individual therapy sessions for each patient, group skills
training sessions, phone coaching and consultation
meetings for the clinicians on the DBT team [11, 12]. In
stage 1 of DBT, which focuses on behavioural stabilisa-
tion, all treatment modalities are delivered on a weekly
basis over the course of a 12 month programme. A sum-
mary of the modes and their functions [11] are outlined
in Table 1.
Group skills training is delivered in blocks of three
modules which teach mindfulness, distress tolerance,
emotion regulation and interpersonal effectiveness. The
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three modules are delivered over a 24-week period and
are then repeated.
DBT-A utilises a similar format to standard DBT and
is delivered by a team of multidisciplinary mental health
professionals. However, as part of the DBT-A adaptation,
the treatment length is reduced from 12 months to
16 weeks [28]. The skills and modules are shortened and
the materials are made more developmentally appropri-
ate for adolescents. In DBT-A, each module is only
taught once. DBT-A also includes an additional module,
Walking the Middle Path, which addresses adolescent
and family dilemmas. In addition, parent/guardians are
included in the weekly skills groups as part of a multi-
family group component.
Treatment adherence
DBT is a principle rather than protocol driven treatment.
It outlines a series of principles to help the practitioner
decide on what to do in a given set of circumstances. The
principles guide the therapist to being treatment adherent
while remaining responsive to individual patient needs
[45]. A diary card (which tracks a person’s urges, mood
and DBT skill use) is used to help structure the individual
therapy session and target which behaviours need a chain
and solution analysis. Treatment adherence will be moni-
tored by means of supervision and review of audio re-
corded individual therapy sessions by supervisors.
Feedback on treatment adherence is then provided to the
clinician by the supervisor.
Concomitant care
Typically patients continue with medical and psychiatric
treatment but are not engaged in other psychotherapy at
the time of the DBT intervention.
Outcome measures
Effectiveness evaluation
Primary outcome measures for patients in this study will
directly map onto DBT treatment targets which are:
 reduction of life threatening behaviours
 reduction of treatment interfering behaviours
 reduction of quality of life interfering behaviours
 increase in skill utilisation
More specifically, the treatment target, corresponding
measurement variables, and participant groups are out-
lined in Table 2:
Secondary outcome measures will also be completed
by DBT therapists to provide an objective perspective on
patient functioning at each time point. The measures
completed by DBT therapists for adult participants are
the Global Assessment of Functioning [46] and the
Health of the Nation Outcome Scales [47]. The corre-
sponding adolescent versions of these scales were used
for the adolescent participant group [48, 49].
Constructs relevant for family members of individuals
with behavioural and emotional dysregulation are
assessed through scales which measure parental stress
[50], burden [51] and grief [52].
Implementation evaluation
The coordinated implementation (Fig. 1) will be evalu-
ated in the following manner:
The quantity of implementation will be measured
through individual therapy and group skills attendance
logs which are recorded by the DBT therapists on a
weekly basis. These DBT Programme Logs developed for
the purposes of this study (reporting individual therapy
and group skills attendance, self-harm behaviour and
Table 1 Modes and functions of standard DBT for adults
Mode Function Frequency Duration
Individual Therapy Motivation for treatment, treatment goals and skills strengthening Weekly 60 min
Skills Training Enhance patient capabilities – skills acquisition and strengthening Weekly 2.5 h
Phone consultation Assist patients to generalise skills to daily life and in crises As needed 10–15 min
Team Consultation Enhance therapists capabilities and motivation to adhere to DBT,
peer support and prevent burn-out
Weekly 1.5–2 h
Fig. 1 Overview of Implementation Evaluation
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urges, and skills use in the last week) will be used to rec-
ord this information.
The quality of implementation will be measured
through the Programme Elements of Treatment Ques-
tionnaire (PETQ; [53]). DBT therapist’s adherence to
the DBT model will be assessed on an ongoing basis
by the expert DBT supervisor working with each
team. DBT participants’ experience of the programme
will be assessed through a survey which has been
specifically developed for the purpose of this study.
Survey questions request feedback on overall quality
of the intervention, usefulness of content, and effect-
iveness. Experience of the coordinated implementation
will be measured through surveys which have been
developed based on international DBT implementa-
tion research. The surveys will be used to gather in-
formation about DBT therapists’ experiences of the
implementation. Survey questions cover areas includ-
ing training, supervision, implementation facilitators
and barriers, and experience of coordinated
implementation.
Economic evaluation
A client record form (see section on Outcome
Measures) has been developed for DBT therapists to
track detailed information about service utilisation and
resource use by DBT patients. Effectiveness outcome
measures (e.g. EQ-5D-5 L and BDI-II) will also be used
to inform the economic evaluation.
Time point for each outcome
Effectiveness evaluation time points
There will be different time points for each sample in
this study as the treatment length for adult and adoles-
cent patients is different.
For adult patients, the treatment length is 12 months
in duration, so there will be four time points for assess-
ment of outcome: baseline (during the week prior to the
patients’ first group skills training session), 6 months
after baseline (end of module 3), 12 months after base-
line (end of programme), and 18 months after baseline
(6 months after programme completion).
For adolescent patients, the treatment length is
16 weeks in duration, so there will be three time points
for assessment of outcome: baseline (during the week
prior to the patients’ first group skills training session),
16 weeks after baseline (end of programme), and
32 weeks after baseline (16 weeks after programme
completion).
Implementation evaluation time points
The quantity of the implementation is monitored weekly
through recording of individual therapy and group skills
Table 2 Treatment targets, measurement method and reporting method for primary outcomes
Completed by
Treatment target Measure Adults Adolescents DBT Therapists
Life threatening behaviours Self-harm Self-harm Inventory [58] ✓
Client record form2 ✓
E.D. visits Client record form ✓
Hospital
admissions
Client record form ✓
Suicidal Ideation Questionnaire for suicidal ideation ✓ ✓
Treatment interfering
behaviours
Attendance Individual therapy/group skills logs3 ✓
Use of phone
coaching
Phone coaching logs3 ✓
Quality of life interfering
behaviours
Depression Beck Depression Inventory – II [59] Beck Depression
Inventory-Youth [60]
✓ ✓
Borderline
symptoms
Borderline Symptoms Checklist [55] ✓ ✓
Hopelessness Beck Hopelessness Scale [61] ✓ ✓
Quality of life EQ-5D-5 L [62] ✓ ✓
Dysfunctional
coping
DBT Ways of Coping Checklist [63] ✓ ✓
Anger STAXI - 2 [64] STAXI - C/A [65] ✓ ✓
Skill utilisation Skills use DBT Ways of Coping Checklist ✓ ✓
2Developed by research team in consultation with DBT therapists to systematically gather data pertinent to the Irish public health service. Self-harm behaviour
frequency and type, number of Emergency Department visits, and number and duration of acute psychiatric inpatient admissions per patient
3Developed by research team and outlined in more detail under Implementation Evaluation
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weekly attendance logs completed by the DBT therapists
at each site.
The quality of the implementation is measured
through the PETQ which will be administered to team
leaders for completion two years after teams complete
Intensive Training Part I. DBT therapists’ adherence is
assessed on an ongoing basis through expert supervision.
To assess participant’s experience of the DBT
programme, a survey is administered at time points 2, 3
and 4 for adults (alongside self-report outcome mea-
sures) and time points 2 and 3 for adolescents (alongside
self-report outcome measures).
The experience of the coordinated implementation will
be measured by administering surveys to therapists at three
time points: prior to attending Intensive Training Part I,
6 months after teams begin delivery of their first DBT
programme, and 2 years following Intensive Training Part I.
Economic evaluation time points
For adult patients, the treatment length is 12 months in
duration, so there will be four time points for assess-
ment of outcome: baseline (pertaining to 6 months be-
fore the start of the programme), end of module 3
(pertaining to the first 6 months of the programme), end
of programme (pertaining to the second 6 months of the
programme), and 6 months after programme completion
(pertaining to the 6 months following completion of the
programme).
For adolescent patients, the treatment length is
16 weeks in duration, so there will be three time points
for assessment of outcome: baseline (pertaining to
16 weeks before the start of the programme), end of
programme (pertaining to the 16 weeks of the
programme), and 32 weeks after baseline (pertaining to
the 16 weeks following completion of the programme).
Sample size
It is anticipated that there will be a total of 442 partici-
pants across 16 sites in this research study over a four
year period. Of the 312, it is estimated that 120 will be
adults with a primary diagnosis of BPD attending Adult
Mental Health Services across eight study sites. It is esti-
mated that 96 participants will be adolescents with emo-
tional and behavioural dysregulation (emerging
borderline personality presentations) across eight study
sites. As the adolescent’s caregiver also attends the skills
training sessions, there will also be up to 96 parent/
guardian participants. All DBT therapists (approximately
130 clinicians) who train as part of the National DBT
Project, Ireland will be invited to participate in the re-
search study.
The power calculation is based on the aim of identify-
ing if the intervention is effective across multiple sites as
part of a coordinated national implementation with
adults and adolescents. It was decided to use a medium
effect size of 0.5 according to Cohen [54] for the power
calculation with an alpha level of 0.05. The primary out-
come measure chosen for the power calculation is the
Borderline Symptoms Checklist [55]. With an antici-
pated sample size of eight clusters per adult group with
15 patients per cluster, and an intracluster correlation
coefficient of 0.01, the power to detect change over time
is 92%. With an anticipated sample size of eight clusters
per adolescent group with 12 patients per cluster, and an
intracluster correlation coefficient of 0.01, the power to
detect change over time is 86% [56].
Recruitment/procedure
Newly established teams who train as part of the
National DBT Project, Ireland will be requested to in-
form the researchers of the start date of their DBT
programme. All individuals who partake in the DBT
programme at each of the 16 sites between February
2014 and February 2016 will be invited to participate in
the study. A group data collection session will take place
at each time-point at each of the study sites where a
member of the research team will facilitate data collec-
tion. Data collection will be scheduled in advance with
the DBT team at each location. It is anticipated that this
will take place at the beginning of the first skills training
session that is delivered as part of the intervention. Prior
to visiting each site, each DBT team will be provided
with Participant Information Leaflets to distribute to pa-
tients to orientate them towards the research study.
When the researcher attends for data collection, patients
will have had time to read the Participant Information
Leaflet and will have an opportunity to ask any questions
regarding the research study. It will be outlined that
while participation in the study is confidential, there is a
limit to confidentiality. In order to maintain safety of
patients, the researchers will conduct a risk assessment
following data collection at each site, the results of
which are communicated to the DBT therapist(s)
present. Participants who are unable to attend the group
data collection session but who have agreed to partici-
pate in the study will be asked to complete the battery
of measures at their next individual therapy session.
These participants will sign the consent form, complete
the measures and place the completed measures in a
sealed envelope to be collected by the research team. In
such cases, the protocol outlines that DBT therapists
will review with the patient, only their answers to the
risk assessment items, prior to securely storing the
completed measures.
For follow-up data collection, participants will be in-
vited to attend a group data collection session with a
member of the research team, complete measures with
their DBT therapist or complete measures at home in
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which case, measures will be posted directly to them by
the research team. If participants choose to complete the
measures at home, participants will first be asked to pro-
vide consent for their local General Practitioner to be
contacted should self-harm or suicide risk be identified
upon completion of the measures.
Data analysis
T tests and analyses of variance will be used to assess
potential baseline difference in the outcome measures.
Linear mixed-effects models will be used to estimate
change utilising data available from participants at all
time points. These models may be adjusted for cluster-
ing in the data due to repeated measures on the same in-
dividuals and due to the intervention being delivered
across multiple sites.
Content analyses will be carried out on the survey data
provided by DBT therapists which will inform the imple-
mentation evaluation.
An economic evaluation will be performed to assess
the cost-effectiveness of DBT versus treatment-as-usual
for the treatment of adults with BPD who engage in self-
harm. The cost-effectiveness analysis will compare the
relative costs and outcomes (effects) of the DBT
intervention. All relevant costs from the perspective of
the health care provider will be identified, measured and
valued. Direct health service use will be measured by
means of a resource use questionnaire. The relevant
health effects will be measured in natural health units
using recognised scales, for example, the Beck Depres-
sion Inventory. In addition, Quality Adjusted Life Years
(QALY) will be calculated with the EQ-5D-5 L utility
scores. An incremental Cost Effectiveness Ratio (ICER)
will be calculated comparing the relative costs and out-
comes. The economic evaluation will be conducted in
line with the eight-step framework put forward by
Drummond et al. [57].
Ethical principles
The participation in the study is voluntary. Participants
are informed that if they decide not to participate in the
study that this will not affect their treatment in any way.
Participants are informed that they can withdraw their
participation at any time without providing a reason. All
participants are asked to sign an informed consent form.
Ethics approval
Research ethics approval was sought and obtained from
all relevant research ethics committees at the multiple
sites of this research study.
Discussion
The study protocol is outlined here to offer clinicians
and researchers in publically funded health systems an
opportunity to consider the methodological quality of
this effectiveness study with a critical view. Publicly
funded health systems may benefit from considering
how the proposed protocol could be applied to out-
patient mental health settings which treat individuals
with emotional and behavioural dysregulation. There are
a limited number of effectiveness studies looking at
standard stage 1 DBT in public mental health settings.
Research on effectiveness of DBT when implemented in
a coordinated manner could provide an important
contribution to improving routine mental health care for
patients with BPD.
The protocol also offers clarity on quality, quantity
and experience of participating in a coordinated imple-
mentation of DBT at a national level. This could poten-
tially provide evidence on how best to overcome barriers
to implementation in publicly funded health systems.
The economic evaluation which is carried out as part
of this research study will provide important information
on the cost of BPD illness to a public health service
which will facilitate international comparison. In
addition, evaluating the cost of implementing DBT in a
coordinated manner in comparison to treatment-as-
usual will provide support for the value of robust appli-
cation of an evidence-based intervention which is also in
line with best practice guidelines.
One of the limitations in previous research on DBT
effectiveness is the variability in outcome measures
utilised to assess clinical effectiveness. This protocol
specifically matches outcome measures to treatment
targets for DBT in an attempt to create a standar-
dised battery of measures that can be applied across
any research setting. Evidence on effectiveness, re-
source utilisation and feedback from both patients
and therapists will shape systemic culture change in
how we treat individuals with chronic self-harm and
suicidal behaviours.
As this study is carried out in a publicly funded health
system, this study considers how this treatment might
be applied to multiple patient groups, in this case adults
and adolescents. No study to our knowledge has re-
ported on the effectiveness of the 16-week DBT
programme as described by Miller and colleagues [28]
for adolescents in community settings so it is anticipated
that the results of this study will also contribute to this
gap in the literature.
Strengths and limitations
As this study is carried out in a real-world setting, DBT
therapists do not have dedicated time to devote to
research related tasks, as would be the case in a clinical
research trial. Therapists are therefore participating in a
voluntary capacity in addition to daily routine and
regular professional practice. Given the nature of this
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comprehensive evaluation, it is anticipated that full com-
pliance with the data collection protocol may not always
be possible with competing clinical demands. In an ef-
fort to offset this risk, each team will be supported by a
member of the coordinating team who will provide guid-
ance and assistance with the research evaluation where
possible. In addition, in real-world settings, therapists
have a mixed qualification and skill set in relation to re-
search related tasks in contrast to those specifically re-
cruited to support clinical research trials.
One of the strengths of this study is that a dedicated
research team has been recruited to coordinate and sup-
port this multi-site research evaluation. This was done
in an effort to reduce experimenter bias which may be
present if clinicians who are working with patients con-
duct data collection. It is anticipated that having a dedi-
cated research team will also increase the reliability and
quality of data collection at agreed time points, and will
allow for follow-up data collection to maximise dataset
completeness. Having a researcher assigned to each team
who will support clinicians during the process of the
study will also potentially increase response rates and
dataset completeness. Feedback will be provided to each
participating service and updates will be provided re-
garding recruitment status on a regular basis by the re-
search team. At the end of the study, summary reports
of the results for each individual site, in addition to the
pooled data analysis, will be provided to each team to
provide feedback to clinicians and aid service planning.
The outlined difficulties with regard to real-world re-
search needs to be managed if researchers and clinicians
are to work towards increasing external validity i.e. the
effectiveness of an intervention in a publicly funded
health system implemented in a manner that is sustain-
able over time.
Although one of the challenges in conducting effect-
iveness studies is inclusion of data from a control
group, the current study hopes to obtain a compari-
son group by utilising data collected from treatment-
as-usual patients in areas with no DBT provision or
where patients opted out of treatment. While real-
world challenges prohibit a randomised controlled de-
sign in a community setting, there is still merit in
having a comparison group who do not receive treat-
ment for the purposes of the evaluation.
The comprehensive research evaluation includes both
quantitative and qualitative feedback from multiple
perspectives including that of the patient, their family
member (in the case of adolescents) and their therapist.
Such comprehensive and robust evaluation will serve to
inform the real value of DBT as an intervention when
delivered in a publicly funded health setting and will
potentially serve to inform our system to refine and
increase sustainability of service provision over time.
The advantage of having a multi-site study is that it
yields a larger sample size. A strength of this study is
that we have sufficient power in both the adult and ado-
lescent populations to answer the research question as
to whether DBT, if delivered in a coordinated manner,
will produce positive outcomes for patients in a publicly
funded health system.
This study will potentially provide evidence to endorse
DBT as an evidence-based treatment that can be effect-
ively delivered in community settings for high risk indi-
viduals. This approach will potentially lend itself to
better coordinated interventions and public health
system changes that may reduce the need for repeated
emergency department attendances and protracted
periods of acute hospitalisations.
Endnotes
1In 2013, recommendations by BiDBT allowed up to a
maximum of ten members per DBT team. This has since
been revised and current training requirements allow a
maximum of eight team members.
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